Related Experiment Video
Updated: Mar 9, 2026
Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
Multimodality Technologies in the Assessment of Hematolymphoid Neoplasms
Shiyong Li, David L Jaye, Kyle T Bradley
1From the Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
Insights
Accurate diagnosis of hematolymphoid neoplasms requires integrating morphology, immunophenotyping, and genotypic studies. This multiparameter approach aids in classification, treatment stratification, and monitoring disease response.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Morphologic examination by light microscopy is the primary method for assessing hematolymphoid neoplasms.
- Immunophenotypic analysis (immunohistochemistry, flow cytometry) is crucial for differentiation and detecting minimal residual disease.
- Genotypic studies are essential for precise subclassification according to the World Health Organization classification.
Purpose of the Study:
- To highlight the necessity of an integrated multiparameter approach for accurate hematolymphoid neoplasm assessment.
- To emphasize the complementary roles of morphology, immunophenotyping, and genotypic studies.
- To underscore the impact of these methods on targeted immunotherapy, prognostication, and treatment monitoring.
Main Methods:
- Light microscopy for initial morphologic assessment.
- Immunophenotypic analysis including immunohistochemistry and flow cytometry.
- Genotypic studies such as cytogenetics, FISH, DNA microarray, PCR, and next-generation sequencing.
Main Results:
- Morphology provides initial assessment, while immunophenotyping clarifies differentiation and detects minimal disease.
- Genotypic studies enable precise subclassification, clonality assessment, and treatment stratification.
- Integrated approaches enhance diagnostic accuracy and guide therapeutic decisions.
Conclusions:
- An integrated multiparameter approach combining morphology, immunophenotyping, and genotypic studies is indispensable for accurate hematolymphoid neoplasm diagnosis.
- This comprehensive strategy is vital for subclassification, determining appropriate treatments, and monitoring patient response.
- Utilizing these advanced techniques improves patient outcomes through personalized medicine and precise disease management.
Abstract:
Accurate assessment of tissues for hematolymphoid neoplasms requires an integrated multiparameter approach. Although morphologic examination by light microscopy remains the mainstay of initial assessment for hematolymphoid neoplasms, immunophenotypic analysis by immunohistochemistry and/or flow cytometry is essential to determine the pattern of differentiation and to detect minimal disease when morphology is inconclusive. In some cases, immunophenotypic analysis provides additional information for targeted immunotherapy and prognostication. Genotypic studies, including cytogenetics, fluorescence in situ hybridization, DNA microarray, polymerase chain reaction, and/or next-generation sequencing, are also imperative for subclassification of the genetically defined disease entities in the current World Health Organization classification of hematolymphoid neoplasms. Moreover, genotypic studies can establish clonality, stratify patients to determine appropriate treatment, and monitor patients for treatment response.
